Document Detail

Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases.
MedLine Citation:
PMID:  20942809     Owner:  NLM     Status:  MEDLINE    
The severity of Hashimoto's disease (HD) and intractability (or inducibility to remission) of Graves' disease (GD) varies among patients. Forkhead box P3 (FoxP3) is a crucial regulatory factor for the development and function of regulatory T (T(reg) ) cells, and deficiency of the FoxP3 gene (FOXP3) suppresses the regulatory function of T(reg) cells. To clarify the association of the functional polymorphisms of the FOXP3 with the prognosis of GD and HD, we genotyped -3499A/G, -3279C/A and -2383C/T polymorphisms in FOXP3 gene obtained from 38 patients with severe HD, 40 patients with mild HD, 65 patients with intractable GD, in whom remission was difficult to induce, 44 patients with GD in remission and 71 healthy volunteers. The -3279CA genotype was more frequent in patients with GD in remission than in patients with intractable GD, and the -3279AA genotype, which correlates to defective transcription of FOXP3, was absent in patients with GD in remission. The -2383CC genotype was more frequent in patients with severe HD than in those with mild HD. In conclusion, the -3279A/C polymorphism is related to the development and intractability of GD and the -2383CC genotype to the severity of HD.
N Inoue; M Watanabe; M Morita; R Tomizawa; T Akamizu; K Tatsumi; Y Hidaka; Y Iwatani
Related Documents :
9269639 - Abnormal cyanide metabolism in uraemic patients.
18029159 - Modulation of erythrocyte sensitivity to oxidative stress by transient hyperhomocystein...
12920629 - Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients.
18078369 - Variability of acetylcholinesterase hyperinnervation patterns in distal rectal suction ...
16510149 - Serum matrix metalloproteinase-2 and increased oxidative stress are associated with car...
8445839 - Dialysis therapy in the elderly patient.
11760819 - Eight years of unexplained headaches (why did the diagnosis take so long?).
16919009 - Bosentan in eisenmenger syndrome and chronic thromboembolic pulmonary hypertension.
18191989 - Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid a...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-05
Journal Detail:
Title:  Clinical and experimental immunology     Volume:  162     ISSN:  1365-2249     ISO Abbreviation:  Clin. Exp. Immunol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-12     Completed Date:  2011-03-08     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  0057202     Medline TA:  Clin Exp Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  402-6     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.
Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1-7 Suita, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Disease Progression
Forkhead Transcription Factors / genetics*
Genetic Association Studies
Graves Disease / diagnosis*,  drug therapy,  genetics*,  physiopathology
Hashimoto Disease / diagnosis*,  drug therapy,  genetics*,  physiopathology
Middle Aged
Polymorphism, Single Nucleotide
Promoter Regions, Genetic
Remission Induction
Reg. No./Substance:
0/FOXP3 protein, human; 0/Forkhead Transcription Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cnh1 Na(+) /H(+) antiporter and Ena1 Na(+) -ATPase play different roles in cation homeostasis and ce...
Next Document:  cAMP- and Ca²(+) /calmodulin-dependent protein kinases mediate inotropic, lusitropic and arrhythmog...